Paul Bridges, Ph.D.

Paul heads Parexel's Regulatory & Access organization worldwide and is currently based in Dublin Ireland.

Work Experience

Prior to his current role, Paul headed the Americas Integrated Product Development (IPD). He earlier served as Vice President European Account Management for Parexel Consulting after a term as Senior Director of the consultancy’s regional UK IPD consulting team. Paul originally joined Parexel as a Principal Consultant providing strategic regulatory advice on all aspects of drug development with a special focus on Chemistry, Manufacturing and Controls (CMC).

Prior to Parexel Consulting, Paul was European Director of Regulatory Affairs for INO Therapeutics, and a pharmaceutical assessor for the UK Licensing Authority (MCA) with specific expertise in chemistry, manufacturing and controls (CMC). He has extensive knowledge of the European licensing procedures from the perspectives of both industry and regulatory authorities, covering diverse therapeutic areas.

Education

During his Ph.D., Paul studied the pulmonary delivery of drugs and has published work in this field. He is a member of the British Institute of Regulatory Affairs, the European Society of Regulatory Affairs, the Royal Pharmaceutical Society of Great Britain and the Royal Society of Medicine